S&P 500   3,261.90 (-1.46%)
DOW   26,385.81 (-1.03%)
QQQ   270.61 (-2.09%)
AAPL   109.44 (-5.10%)
MSFT   202.36 (-1.15%)
FB   265.21 (-5.56%)
GOOGL   1,632.27 (+4.84%)
AMZN   3,072.24 (-4.32%)
TSLA   391.73 (-4.65%)
NVDA   501.80 (-3.68%)
BABA   304.69 (-2.52%)
CGC   18.50 (-1.49%)
GE   7.38 (+0.14%)
MU   50.01 (-0.93%)
AMD   75.39 (-3.37%)
T   26.90 (+0.52%)
F   7.73 (-2.15%)
ACB   3.94 (-3.67%)
GILD   57.80 (-1.25%)
NIO   31.04 (-2.97%)
NFLX   481.44 (-4.52%)
BA   143.75 (-3.06%)
DIS   120.77 (-0.63%)
S&P 500   3,261.90 (-1.46%)
DOW   26,385.81 (-1.03%)
QQQ   270.61 (-2.09%)
AAPL   109.44 (-5.10%)
MSFT   202.36 (-1.15%)
FB   265.21 (-5.56%)
GOOGL   1,632.27 (+4.84%)
AMZN   3,072.24 (-4.32%)
TSLA   391.73 (-4.65%)
NVDA   501.80 (-3.68%)
BABA   304.69 (-2.52%)
CGC   18.50 (-1.49%)
GE   7.38 (+0.14%)
MU   50.01 (-0.93%)
AMD   75.39 (-3.37%)
T   26.90 (+0.52%)
F   7.73 (-2.15%)
ACB   3.94 (-3.67%)
GILD   57.80 (-1.25%)
NIO   31.04 (-2.97%)
NFLX   481.44 (-4.52%)
BA   143.75 (-3.06%)
DIS   120.77 (-0.63%)
S&P 500   3,261.90 (-1.46%)
DOW   26,385.81 (-1.03%)
QQQ   270.61 (-2.09%)
AAPL   109.44 (-5.10%)
MSFT   202.36 (-1.15%)
FB   265.21 (-5.56%)
GOOGL   1,632.27 (+4.84%)
AMZN   3,072.24 (-4.32%)
TSLA   391.73 (-4.65%)
NVDA   501.80 (-3.68%)
BABA   304.69 (-2.52%)
CGC   18.50 (-1.49%)
GE   7.38 (+0.14%)
MU   50.01 (-0.93%)
AMD   75.39 (-3.37%)
T   26.90 (+0.52%)
F   7.73 (-2.15%)
ACB   3.94 (-3.67%)
GILD   57.80 (-1.25%)
NIO   31.04 (-2.97%)
NFLX   481.44 (-4.52%)
BA   143.75 (-3.06%)
DIS   120.77 (-0.63%)
S&P 500   3,261.90 (-1.46%)
DOW   26,385.81 (-1.03%)
QQQ   270.61 (-2.09%)
AAPL   109.44 (-5.10%)
MSFT   202.36 (-1.15%)
FB   265.21 (-5.56%)
GOOGL   1,632.27 (+4.84%)
AMZN   3,072.24 (-4.32%)
TSLA   391.73 (-4.65%)
NVDA   501.80 (-3.68%)
BABA   304.69 (-2.52%)
CGC   18.50 (-1.49%)
GE   7.38 (+0.14%)
MU   50.01 (-0.93%)
AMD   75.39 (-3.37%)
T   26.90 (+0.52%)
F   7.73 (-2.15%)
ACB   3.94 (-3.67%)
GILD   57.80 (-1.25%)
NIO   31.04 (-2.97%)
NFLX   481.44 (-4.52%)
BA   143.75 (-3.06%)
DIS   120.77 (-0.63%)
Log in
NASDAQ:HEXO

HEXO Stock Forecast, Price & News

Lowest-Rated Stocks  
$0.59
-0.13 (-17.38 %)
(As of 10/30/2020 12:27 PM ET)
Add
Compare
Today's Range
$0.55
Now: $0.59▼
$0.65
50-Day Range
$0.64
MA: $0.72▼
$0.80
52-Week Range
$0.35
Now: $0.59▼
$2.70
Volume290,492 shs
Average Volume9.93 million shs
Market Capitalization$287.26 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.
Read More

Beat the Market (BTM) Rank™

Analyst Opinion: 2.8Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.01 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HEXO
Previous Symbol
CUSIPN/A
CIKN/A
Webhexo.com
Phone844-406-1852
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares483,445,000
Market Cap$287.26 million
Next Earnings DateN/A
OptionableOptionable
$0.59
-0.13 (-17.38 %)
(As of 10/30/2020 12:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HEXO News and Ratings via Email

Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











HEXO (NASDAQ:HEXO) Frequently Asked Questions

How has HEXO's stock price been impacted by Coronavirus?

HEXO's stock was trading at $0.9376 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HEXO stock has decreased by 36.7% and is now trading at $0.5931.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of HEXO?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 9 sell ratings, 7 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for HEXO.

How were HEXO's earnings last quarter?

HEXO Corp. (NASDAQ:HEXO) announced its earnings results on Thursday, June, 11th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.02. The company had revenue of $22.48 million for the quarter, compared to analysts' expectations of $14.19 million.
View HEXO's earnings history.

What price target have analysts set for HEXO?

17 brokerages have issued 1-year price targets for HEXO's stock. Their forecasts range from $0.75 to $2.00. On average, they anticipate HEXO's stock price to reach $1.22 in the next year. This suggests a possible upside of 105.8% from the stock's current price.
View analysts' price targets for HEXO.

Who are some of HEXO's key competitors?

Some companies that are related to HEXO include Knight Therapeutics Inc. (GUD.TO) (GUD), Aurora Cannabis Inc. (ACB.TO) (ACB), HLS Therapeutics (HLS), Amryt Pharma plc (AMYT.L) (AMYT), OrganiGram (OGI), Benchmark (BMK), ICC Labs Inc. (ICC.V) (ICC), Shield Therapeutics plc (STX.L) (STX), ESSA Pharma Inc. (EPI.V) (EPI), cbdMD (YCBD), The Green Organic Dutchman Holdings Ltd. (TGOD.TO) (TGOD), WeedMD Inc. (WMD.V) (WMD), Delta 9 Cannabis (NINE), Venture Life Group plc (VLG.L) (VLG) and Diurnal Group (DNL).
View all competitors.

What other stocks do shareholders of HEXO own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), Cronos Group (CRON), OrganiGram (OGI), KushCo (KSHB), Charlotte's Web (CWBHF), Tilray (TLRY), Aurora Cannabis Inc. (ACB.TO) (ACB) and NVIDIA (NVDA).

Who are HEXO's key executives?

HEXO's management team includes the following people:
  • Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 35)
  • Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 35)
  • Mr. Ed Chaplin, CFO & Corp. Sec. (Age 49)
  • Mr. James McMillan, VP of Bus. Devel. (Age 51)
  • Dr. Terence Lake DVM, Vice-Pres of Corp. & Social Responsibility

What is HEXO's stock symbol?

HEXO trades on the NASDAQ under the ticker symbol "HEXO."

How do I buy shares of HEXO?

Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HEXO's stock price today?

One share of HEXO stock can currently be purchased for approximately $0.59.

How big of a company is HEXO?

HEXO has a market capitalization of $286.73 million.

What is HEXO's official website?

The official website for HEXO is hexo.com.

How can I contact HEXO?

The company can be reached via phone at 844-406-1852.

This page was last updated on 10/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.